Molecular Imaging, a contract research organization (CRO) providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, has entered into a licensing agreement with Dana-Farber Cancer Institute in Boston to access a number of luciferase-enabled cancer cell lines developed at Dana-Farber.
Phantom and in vivo experiments have demonstrated the feasibility of simultaneous PET and 3D fluorescence optical tomography (FOT) imaging, according to research published in the August issue of the Journal of the Nuclear Medicine.
Caliper Life Sciences of Hopkinton, Mass., and Carestream Health of Rochester, N.Y., have settled two lawsuits.
Bruker has released the BioSpec 150/11 system, an ultra-high-field MRI scanner for preclinical research for molecular and microscopic imaging.
The University of Notre Dame in South Bend, Ind., has added Carestream Molecular Imaging’s Albira system to its In Vivo Imaging Core, part of the Notre Dame Integrated Imaging Facility.
PET technology is a powerful tool for in vivo analysis of the gastrointestinal absorption of orally administered drugs, based on a study of conscious and anesthetized rats, published in the February issue of the Journal of Nuclear Medicine.
RSS 
